Naoki Koshimizu

Prognostic Factors for Myositis-Associated Interstitial Lung Disease

Tomoyuki Fujisawa, Hironao Hozumi, Masato Kono et al. · PLoS ONE · 2014 · 167 citations · Full text

Medicine, Internal Medicine, Pathology +15

Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study

Yasunori Enomoto, Yutaro Nakamura, Yasuomi Satake et al. · Respiratory Medicine · 2017 · 127 citations · Full text

Medicine, Pathology, Surgery +7

Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients

Hideki Kusagaya, Yutaro Nakamura, Masato Kono et al. · BMC Pulmonary Medicine · 2012 · 96 citations · Full text

Medicine, Clinical Sciences, Pathology +16

Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated <scp>ILD</scp>: A randomized, open‐label trial

Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya et al. · Respirology · 2020 · 53 citations

Pharmacy, Internal Medicine, Pharmacotherapy +13

Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD)

Takafumi Suda, Masato Kono, Yutaro Nakamura et al. · Respiratory Medicine · 2010 · 52 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +9